Industry & Business

156K cancer patients could miss out on life-saving drugs every year in US and Europe

 Breaking News
  • Cyber attack hits IT systems in Ireland and UK Several organisations including big business and government offices in eastern Europe have been hit by a worldwide cyber attack. It has been reported that companies in Ireland may also have been affected, with computer systems at shipping group Maersk failing across regions including Ireland. Danish, British and Spanish multinationals have also been hit by the [...]...
  • Irish and UK retailers highlight Brexit challenges Retail Ireland, the Ibec group that represents the sector, has joined forces with the British Retail Consortium and the Northern Ireland Retail Consortium to explore the implications for the sector arising from Brexit. They will meet in Dublin with a number of Government Departments, consumer advocates and individual retailers to seek solutions to mitigate the [...]...
  • Best ever month of May for Irish tourism Commenting on figures published today by the CSO for overseas visitors to Ireland for January to May, Niall Gibbons, CEO of Tourism Ireland, said: “I am pleased to see growth of more than +3% for the five-month period January-May, coming on the back of a record performance in 2016 and years of solid growth in [...]...
  • New CEO at Barclays Bank Ireland Barclays Bank Ireland has announced the appointment of Kevin Wall as its new chief executive. He succeeds Sarah Wiggins who will take up a new role within Barclays as head of east and south east in UK corporate banking next month. Mr Wall joined Barclays in 1981 and has held a variety of roles across the business, [...]...
  • €330,000 funding announced for ‘Women’s Rural Entrepreneurial Network’ New funding has been announced for female entrepreneurs living in Cork and Limerick. The Women’s Rural Entrepreneurial Network (WREN) project will see more than €330,000 in funding, provided by the Department of Justice and Equality and the European Social Fund, allocated to promote entrepreneurial skills amongst women in these regions, through a tailored and focused [...]...

156K cancer patients could miss out on life-saving drugs every year in US and Europe

156K cancer patients could miss out on life-saving drugs every year in US and Europe
May 19
09:00 2017

Irish medtech company Diaceutics has announced research results showing that more than 156,000 cancer patients in the US and Europe could be missing out on targeted life-saving drugs every year due to suboptimal diagnostic testing – therefore potentially affecting their chances of survival. The company has also found that substandard testing practices are causing pharmaceutical companies in the US and Europe to miss out on up to €15 billion in potential revenues annually.

Every year, 1.7 million cancer patients in the US and Europe undergo tests that determine whether or not there are precision drugs available that are likely to work better with their genetic makeup than more widely prescribed drugs. However, suboptimal testing practices – such as delayed reporting of test results, false negatives and sample management issue – mean that patients and pharmaceutical companies are missing out.

Diaceutics estimates that the figures are in fact much higher, as its data doesn’t take into account the number of patients that aren’t tested at all. The company’s research has found that even some four years after new diagnostic tests become available, just 50% of patients that may be eligible for precision drugs will have been tested by their physician. That, along with suboptimal testing practices, could be causing pharmaceutical companies to be missing out on up to €50 billion annually.

By providing pharmaceutical companies with valuable insights driven by patient testing data, Diaceutics helps them to reach more patients that need to be on specific – and often life-saving – drugs and roll out those drugs faster. The company’s data is gathered through partnerships with more than 230 laboratories that process diagnostic tests. Through its work, Diaceutics has so far helped with the planning and or launch of more than 200 drugs worldwide.

Peter Keeling, CEO, Diaceutics, said: “Precision medicine is already making a huge impact on people’s lives. However, due to questionable diagnostic test practices, patients are missing out on live-saving drugs, while pharmaceutical companies are missing out on the opportunity to reach those patients. Our real-world, real-time research is showing the gaps that exist today.

“Many of the oncology patients that are tested for precision drugs are seriously ill. Physicians therefore need to be able to see the results of those tests as soon as possible. However, novel tests often suffer from issues with sample management, high rates of false negatives and delayed turnaround times, which lead to patients missing out on the drugs they need and therefore potentially facing a much bleaker prognosis.

“Diaceutics is working to change this by bridging the gap between pharmaceutical companies and diagnostics. We work with hundreds of lab partners across the world, gathering and analysing their patient testing data so that we can better understand testing practices. Labs are often severely constrained by ever-reducing reimbursement, yet our demands on them are increasing. Along with our pharma clients, we are working directly with labs to optimise testing. Our data and analytical insights also help pharmaceutical companies understand testing patterns and more effectively integrate proper diagnostic testing into patients’ treatment journeys.

“Medicine is going to become increasingly reliant on diagnostics in the future. In the next 48 months, some 300 new test-dependent drugs or indications will be brought to market. We therefore need to make sure that labs, pathologists, physicians and pharmaceutical companies are perfectly aligned to prepare for this change and ensure patients are receiving the targeted drugs that have the potential to save their lives.”

About Author

editor

editor

Related Articles






Advertisements

































National Manufacturing Conference & Exhibition 2016

NIBRT Springboard Success Stories



Upcoming Events

  • No upcoming events
AEC v1.0.4

Join our Newsletter!



By subscribing you agree to receive updates from us by email. You can opt out of receiving emails at any time.